P21 Peptide P021 Synthetic Research Peptide Lyophilized Powder CAS 1246751-68-7
5 Inquiries
1246751-68-7
Pharmaceutical Grade
99%
Shenzhen
XiWu
5mg*10Vials
2026-09-19
GLP-1,Retatrutide,Selank,Tirzepatide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionResearch & Reference Note
P21 Peptide P021 Synthetic Research Peptide Lyophilized Powder CAS 1246751-68-7 is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Basic Info-
Product Name:
L-Leucinamide, N-acetyl-L-α-aspartylglycylglycyl-N-[3-(aminocarbonyl)tricyclo[3.3.1.13,7]dec-1-yl]-
Other Name:L-Leucinamide, N-acetyl-L-α-aspartylglycylglycyl-N-[3-(aminocarbonyl)tricyclo[3.3.1.13,7]dec-1-yl]-;P21 (P021);Peptide021(P021);L-Leucinamide P21 Peptides
CAS No.:1246751-68-7
Molecular Formula:C27H42N6O8
Molecular Weight:578.66
Categories:
Characteristics-
Density:
1.33±0.1 g/cm3(Predicted)
Boiling Point:1061.4±65.0 °C(Predicted)
PKA:4.23±0.10(Predicted)
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
GLP-1,Retatrutide,Selank,Tirzepatide
-
Location:
Room 307, No. 3, Building 7, Area 4, Pingchou, Jiangdong Street, Yiwu City, Jinhua City, Zhejiang Province
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
1
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
11-50
-
Year of Establishment:
2026
-
-
Inquiry History5 Inquiries
Country Product Purchase Quantity Date Posted 
Canada
P21
10 PCS Jul 8, 2026 
United States
p21
5 MG Apr 28, 2026 
Germany
P21
1 KG Apr 12, 2026
Germany
P21
1 G Apr 6, 2026
Germany
Peptide 021 (P21)
1 Mar 18, 2026 Post an enquiry for this product
